Krystal Biotech Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio50.53320.10
Forward P/E33.30
P/S Ratio15.5169.02
P/B Ratio4.764.493.912.944.05
Price/Tangible Book4.764.493.912.944.05
Price/FCF37.80
Price/OCF36.51
Enterprise Value Ratios
EV/Revenue13.1457.38
EV/EBITDA36.14
EV/EBIT37.01
EV/FCF32.04
Profitability & Returns
Return on Equity (ROE)0.10%0.02%-0.25%-0.16%-0.13%
Return on Assets (ROA)0.07%-0.09%-0.13%-0.09%-0.08%
Return on Invested Capital (ROIC)0.32%-0.41%-0.77%-0.74%-1.77%
Return on Capital Employed (ROCE)0.11%-0.12%-0.23%-0.12%-0.11%
Leverage & Solvency Ratios
Debt/Equity0.010.010.020.010.01
Debt/EBITDA0.07
Debt/FCF0.06
Liquidity Ratios
Current Ratio7.2817.7713.3017.1817.80
Quick Ratio6.8817.3513.1417.0217.55
Efficiency Ratios
Asset Turnover0.310.07
Inventory Turnover1.20
Yield & Distribution Ratios
Earnings Yield0.02%0.00%-0.07%-0.04%-0.03%
FCF Yield0.03%-0.03%-0.08%-0.07%-0.03%
Buyback Yield-0.07%-0.09%-0.15%-0.18%-0.18%